NYSE (USD): Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Last Price
49.72
Today's Change
+0.68 (1.38%)
Day's Change
48.52 - 50.15
Trading Volume
65,476
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
2
Trump in Phone Call Advised Putin Not to Escalate in Ukraine — Washington Post
3
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
Hedge Funds Shorting Tesla Just Lost More Than US$5 Bil
5
Trump Seeks Fast Appointments; Elon Musk Makes Endorsement for Senate Leadership
#
Stock
Score
MSTR
MicroStrategy Incorporated
AGN
833
BABA
Alibaba Group Holding Limited
666
KXIN
Kaixin Auto Holdings
BITF
Bitfarms Ltd.
6
AAPL
Apple Inc.
500
7
PLTR
Palantir Technologies Inc.
466
8
CHMT
333
9
TEN
Tenneco Inc.
10
NSC
Norfolk Southern Corporation
Last
Change
Volume
ELAB
0.026
+0.001
1,177,291,398
XTIA
0.081
+0.024
174,157,940
SVMH
0.03
+0.005
157,388,404
LMDX
0.016
-0.018
120,553,903
LILM
0.209
-0.334
112,784,715
UAVS
4.11
+2.50
102,903,002
MVST
0.816
+0.02
97,051,197
NVDA
762.00
-84.71
85,558,284
QUBT
3.66
+1.00
78,230,260
NVR
9,217.09
+111.42
2,217
MKL
1,702.67
+47.31
6,020
ASML
706.04
+32.63
1,185,036
DDS
416.81
+28.30
28,302
SEZL
410.00
+27.91
30,170
AZO
3,188.00
+26.13
7,391
SEB
2,734.56
+18.47
615
FCNCA
2,180.05
+16.98
5,890
BLK
1,046.93
+15.95
132,356
APP
298.83
+14.87
2,134,630
BRK-A
701,217.52
-1,032.50
669
MELI
1,774.05
-343.25
2,940,447
1,309.00
-138.99
2,237,917
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
1,873.31
-57.64
95,437
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....